Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
It is not a drug and is not intended to diagnose, treat, cure, or prevent any disease.
SURPASS-1 (Lancet, 2021) demonstrated Tirzepatides glucose-lowering efficacy in type 2 diabetes (HbA1c reduction of up to 2.59% at 15mg)
Some researchers explore microdosing tirzepatide as an alternative to full-dose protocols, particularly those who experience significant gastrointestinal side effects at standard doses
Heat and direct sunlight degrade the medication
60 capsules per bottle
US$ 26.43
US$ 29.02
US$ 29.76
US$ 27.53
US$ 23.90
US$ 28.65
